REG - CVS Group plc - PDMR Dealing

CVSAnnouncement

28/05/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260528:nRSb9272Fa&default-theme=true

RNS Number : 9272F  CVS Group plc  28 May 2026

 

 28 May 2026

 

CVS Group plc

 

("CVS" or the "Company")

 

PDMR Dealing

CVS, the UK's listed veterinary group and a leading provider of veterinary
services, announces that it was notified on 27 May 2026 that Scott
Morrison, Group General Counsel and Company Secretary of CVS, purchased a
total of 987 ordinary shares of 0.2p each in the Company ("Ordinary Shares")
on the same date.

As a result, Scott Morrison's total interest in the Company, including all
persons closely associated, is now at 987 Ordinary Shares, representing 0.001%
per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of
the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc
 
                                via FGS Global

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

FGS Global (Financial
PR)

Faeth Birch
 
                                  +44 (0)207 251 3801

   Charlie
Chichester                                                                                                           cvsgroup@fgsglobal.com
(mailto:cvsgroup@fgsglobal.com)

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Scott Morrison

 2    Reason for the notification

 a)   Position/status                                              PDMR (Group General Counsel and Company Secretary)

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    On-market purchase

 c)   Price(s) and volume(s)

Price(s) - pence  Volume(s)

                                                                   1,269.681         987
 d)   Aggregated information

                                                                   N/A - single transaction

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      27 May 2026

 f)   Place of the transaction                                     London Stock Exchange (XLON)

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

N/A - single transaction

e)

 

Date of the transaction

 

 

27 May 2026

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHLDLFLQELZBBX



            Copyright 2019 Regulatory News Service, all rights reserved